Brain-Computer Interface (BCI) is a technological system that establishes a direct communication channel between the human brain and computers or external devices, enabling humans to control external devices through brain activity or analyze brain signals from external devices. Below is an in-depth look at eight key players in the BCI sector:
1. **Zhejiang Dongri (600113.SH)** - Listed on the Shanghai Stock Exchange on October 21, 1997, the company primarily operates in agricultural wholesale markets, fresh food distribution, and soybean product processing. - Its subsidiary, Peianmei, has collaborated with Capital Medical University to advance BCI R&D and industrialization. - 2024 revenue: RMB 723 million (-18.44% YoY), with a 5-year CAGR of 7.35%.
2. **Saili Medical (603716.SH)** - Listed on October 31, 2016, Saili specializes in centralized medical operations and in-vitro diagnostics. - Its "Haisi Lingxi" platform focuses on brain science and AI-driven research. - 2024 revenue: RMB 1.811 billion (-9.74% YoY), with a 5-year CAGR of -3.93%.
3. **Xiangyu Medical (688626.SH)** - A leading rehabilitation equipment manufacturer, listed on March 31, 2021. - Develops non-invasive BCI robots for "mind-driven" exoskeletons. - 2024 revenue: RMB 744 million (-0.17% YoY), 5-year CAGR: 10.68%.
4. **Innovation Medical (002173.SZ)** - Listed on September 25, 2007, it provides healthcare services and has made strides in BCI-assisted paralysis recovery. - 2024 revenue: RMB 816 million (+1.3% YoY), 5-year CAGR: 3.03%.
5. **Cytech (300430.SZ)** - Listed on March 19, 2015, Cytech leads in physical therapy and collaborates with CAS on biodegradable BCI chips. - 2024 revenue: RMB 958 million (-18.49% YoY), 5-year CAGR: 5.81%.
6. **Apon Medical (300753.SZ)** - Focused on pain/nasal care devices, listed on December 13, 2018. - Pioneers non-invasive BCI applications. - 2024 revenue: RMB 404 million (-4.35% YoY), 5-year CAGR: -2.29%.
7. **Dnake (300884.SZ)** - Listed on November 12, 2020, Dnake develops smart community security systems and is researching BCI for prosthetic control. - 2024 revenue: RMB 720 million (-18.58% YoY), 5-year CAGR: -1.93%.
8. **Sanbo Brain (301293.SZ)** - A top-tier neurosurgery provider, listed on May 5, 2023. - Integrates BCI systems in clinical practice. - 2024 revenue: RMB 1.429 billion (+8.84% YoY), 5-year CAGR: 9.7%.
*Data sourced from industry reports; investment risks apply. Market volatility requires caution.*